Table 3 Relationship among clinicopathological factors and marker expression patterns
|  | C-survivin* | N-survivin†| ||||
|---|---|---|---|---|---|---|
| Â | Low, n(%) | High, n(%) | P-value | Low, n(%) | High, n(%) | P-value |
Histological growth pattern | Â | Â | Â | Â | Â | Â |
   Tubular, cribriform | 6(100) | 24(77.4) | 0.255 | 12 (85.7) | 18(78.3) | 0.459 |
   Solid | 0(0) | 7(22.6) |  | 2(14.3) | 5(21.7) |  |
Grade | Â | Â | Â | Â | Â | Â |
   Well, moderately | 5(83.3) | 22(71.0) | 0.475 | 12 (85.7) | 15(65.2) | 0.164 |
   Poorly | 1(16.7) | 9(29.0) |  | 2(14.3) | 8(34.8) |  |
Stage | Â | Â | Â | Â | Â | Â |
   I, II | 4(66.7) | 15(48.4) | 0.357 | 10(71.4) | 9(39.1) | 0.357 |
   III, IV | 2(33.3) | 16(51.6) |  | 2(28.6) | 14(51.6) |  |
Tumor size | Â | Â | Â | Â | Â | Â |
   ≤ 3 cm | 5(83.3) | 9(34.6) | 0.043‡ | 8(61.5) | 11(42.1) | 0.057 |
   > 3 cm | 1(16.7) | 17(65.4) |  | 5(38.5) | 8(57.9) |  |
Lymph node involvement | Â | Â | Â | Â | Â | Â |
   Negative | 6(100) | 27(87.1) | 0.476 | 6(46.2) | 11(87) | 0.821 |
   Positive | 0(0) | 4(10.8) |  | 7(53.8) | 3(13) |  |
Bcl-2 | Â | Â | Â | Â | Â | Â |
   Negative | 5(83.3) | 13(41.9) | 0.078 | 10(71.4) | 8(34.8) | 0.031‡ |
   Positive | 1(16.7) | 18(58.1) |  | 4(28.6) | 15(65.2) |  |
Ki-67 | Â | Â | Â | Â | Â | Â |
   Negative | 6(100) | 27(87.1) | 0.476 | 13(92.9) | 20(87) | 0.509 |
   Positive | 0(0) | 4(12.9) |  | 1(7.1) | 3(13) |  |
P53 | Â | Â | Â | Â | Â | Â |
   Negative | 5(83.3) | 23(74.2) | 0.543 | 12(85.7) | 16(69.6) | 0.267 |
   Positive | 1(16.7) | 8(25.8) |  | 2(14.3) | 7(30.4) |  |